-
Mirae Asset Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 21, 2025.
-
The drug category has an estimated annual sale of $122 million in the US. Shares of Lupin were marginally higher in the session, sharply rising after the announcement was made public.
-
Emkay Global Financial is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2500 in its research report dated August 07, 2025.
-
Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 07, 2025.
-
ICICI Securities recommended hold rating on Lupin with a target price of Rs 1950 in its research report dated August 07, 2025.
-
Stocks to Watch Today, 6 August: Stocks like National Securities Depository, Sri Lotus Developers, M&B Engineering, Bharti Airtel, Britannia Industries, Lupin, Prestige Estates Projects, EIH, Gland Pharma, and HG Infra Engineering will be in focus on August 5.
-
The market is expected to remain rangebound and consolidative in the upcoming sessions. Below are some short-term trading ideas to consider.
-
The consolidation is expected to continue, with benchmark indices likely finding support at the 50-day EMA. Below are some short-term trading ideas to consider.
-
Stocks to Watch, 18 July: Stocks like Wipro, Axis Bank, LTIMindtree, Indian Hotels, Lupin, Tracxn Technologies, Capital Small Finance Bank, Veranda Learning Solutions, IndoStar Capital Finance, and Sunteck Realty will be in focus on July 18.
-
Morgan Stanley sees earnings growth in the pharma sector moderating in FY25–27, though robust balance sheets could support investments in high-growth areas.
-
The consolidation is expected to continue until the frontline indices decisively surpass their recent swing highs. Below are some short-term trading ideas to consider.
-
Lupin Share Price | Loteprednol Etabonate Ophthalmic Gel is bioequivalent to Lotemax SM Ophthalmic Gel of Bausch & Lomb Inc and will be manufactured at Pithampur facility in India.
-
Stocks to Watch, 2 July: Stocks like HDB Financial Services, Hero MotoCorp, Sambhv Steel Tubes, Lupin, JSW Energy, Asian Paints, RITES, Paras Defence and Space Technologies, Maruti Suzuki India, and Hyundai Motor India will be in focus on July 2
-
The market may remain rangebound in the upcoming session until it decisively surpasses the previous day’s high. Below are some short-term trading ideas to consider.
-
ICICI Securities recommended hold rating on Lupin with a target price of Rs 2,110 in its research report dated May 16, 2025.
-
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2,200 in its research report dated May 15, 2025.
-
-
Lupin Share Price | Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin’s Nagpur facility in India.
-
Stocks to Watch, 09 May: Stocks like Dilip Buildcon, Multi Commodity Exchange of India, Biocon, IIFL Finance, Pidilite Industries, Chambal Fertilisers and Chemicals, Zee Entertainment Enterprises, Jindal Stainless, REC, Kalyan Jewellers India, Venus Pipes and Tubes, Lupin, and Bharat Petroleum Corporation will be in focus on May 9.
-
The USFDA is expected to submit a report within 180 days of the order, reviewing regulations and guidance on development of domestic pharma manufacturing. The Executive Order also proposes steps to eliminate ' duplicative or unnecessary requirements' in regulations.
-
Tolvaptan slows down the deterioration of kidney function in adults who are at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).
-
The positive momentum is expected to persist in the upcoming sessions, despite potential consolidation. Below are some trading ideas for the near term.
-
Stocks to Watch, 17 Apr: Stocks like Waaree Renewable Technologies, GTPL Hathway, Prestige Estates Projects, UltraTech Cement, Bharat Heavy Electricals, Indian Railway Finance Corporation, SML Isuzu, Petronet LNG, SBI Cards and Payment Services, Glenmark Pharmaceuticals, Tata Steel, Ballarpur Industries, and Karnataka Bank will be in focus on April 17.
-
Some estimates had projected Myrbetriq to contribute close to $30 million each to the quarterly sales of both the pharma companies, a note by Equirus said, suggesting a possible financial penalty as well.
-
Stocks to Watch, 3 Apr: Stocks like South Indian Bank, ESAF Small Finance Bank, Hindustan Zinc, Punjab & Sind Bank, Central Bank of India, Elpro International, Authum Investment & Infrastructure, Reliance Industries, Caplin Point Laboratories, Hindustan Copper, Fortis Healthcare, and Identixweb will be in focus on April 3.
